Vanda Pharmaceuticals
VNDA
VNDA
146 hedge funds and large institutions have $207M invested in Vanda Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
-5
Holders Change %
-3.31%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
53
Reduced
44
Closed
25
Calls
$261K
Puts
$212K
Net Calls
+$49K
Net Calls Change
-$1.26M
Top Buyers
1 |
1
Morgan Stanley
New York
|
$6.42M |
2 |
2
BlackRock
New York
|
$43.6M |
3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$1.3M |
4 |
4
Millennium Management
New York
|
$3.2M |
5 |
5
Citadel Advisors
Miami,
Florida
|
$1.83M |